Most AI imaging companies typically develop individual models tailored to specific diseases. However, a Cambridge-based startup has taken a different approach by raising $20m to create a unified AI model for the entire chest. This foundational model can then be adapted to address various conditions. Qureight specializes in AI imaging tools aimed at clinical trials for lung and heart diseases. Their recent $20m Series B funding round was led by Molten Ventures.
Back
